Procarbazine
Back to searchMolecule Structure
Scientific Name
Procarbazine
Description of the Drug
Procarbazine is an antineoplastic agent indicated for the treatment of stage III and stage IV Hodgkin’s disease in combination with other chemotherapeutic agents.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01168
http://www.drugbank.ca/drugs/DB01168
Brand Name(s)
Not Available
Company Owner(s)
Leadiant Biosciences Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| DNA | NUCLEIC-ACID | INHIBITOR | CHEMBL2311221 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL4656 | ||
| PharmGKB | PA451112 | ||
| Human Metabolome Database | HMDB0015299 | ||
| DrugBank | DB01168 | ||
| PubChem: Thomson Pharma | 15195970 | ||
| PubChem | 4915 | ||
| Mcule | MCULE-9065058360 | ||
| LINCS | LSM-2272 | ||
| Nikkaji | J3.018J | ||
| BindingDB | 50247906 | ||
| EPA CompTox Dashboard | DTXSID4021189 | ||
| DrugCentral | 2272 | ||
| Brenda | 30881 | ||
| ChemicalBook | CB4185420 | ||
| Guide to Pharmacology | 7278 | ||
| rxnorm | MATULANE | PROCARBAZINE | PROCARBAZINE HYDROCHLORIDE |
| KEGG Ligand | C07402 | ||
| ChEBI | 71417 | ||
| ZINC | ZINC000019166988 |
